Characterization of IDO1 and TDO2 in pediatric central nervous system tumors

被引：0
|
作者：
Lauing, Kristen
Lulla, Rishi
Zhai, Lijie
Hashizume, Rintaro
Fangusaro, Jason
Wainwright, Derek A.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 11期
关键词：
D O I：
10.1158/2326-6066.IMM2016-A051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A051
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IMMUNOSUPPRESSIVE IDO1 AND TDO ARE EXPRESSED IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
    Lauing, Kristen L.
    Lulla, Rishi R.
    Hashizume, Rintaro
    Wainwright, Derek A.
    NEURO-ONCOLOGY, 2016, 18 : 173 - 173
  • [2] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [4] On the non-redundant roles of TDO2 and IDO1
    Puccetti, Paolo
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [5] Essential roles of the expression of IDO1 and TDO2 in Bladder Cancer
    Pham, Thang Q.
    Nguyen, Tu T.
    Nguyen, Quyen T.
    Luu, Tung D.
    Pham, Diem T.
    Bui, Tam T.
    Duong, Tu T.
    Phan, Thu D.
    Ngo, Dat Q.
    CANCER SCIENCE, 2023, 114 : 1965 - 1965
  • [6] In silico discovery and therapeutic potential of IDO1 and TDO2 inhibitors
    Jernigan, Finith E.
    Sun, Lijun
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (12) : 1309 - 1311
  • [7] Treatment of IDO1 and TDO2 positive tumors with a kynurenine-degrading enzyme: A highly differentiated approach from IDO1 inhibition
    Coma, Silvia
    Cavanaugh, Jillian
    Nolan, James
    Tchaicha, Jeremy
    McGovern, Karen
    Stone, Everett
    Blazeck, John
    Lamb, Candice
    Georgiou, George
    Manfredi, Mark G.
    Zhang, Michelle
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [8] Small molecule modulators to understand the role of IDO1 and TDO2 in cancer
    Garapaty, Shivani Rao
    Sivanandhan, Dhanalakshmi
    Seerapu, Guru Pavan Kumar
    Naidu, Surendra
    Chakelam, Shalini
    Nagaraj, Pradeep
    Das, Reshma
    Vadivelu, Saravanan
    Iyer, Pravin
    Mulakala, Chandrika
    Murugan, Kannan
    Mondal, Somnath
    Gautam, Anjali
    Kandan, Saravanan
    Thakur, Manish Kumar
    Rajagopal, Sridharan
    Rajagopal, Sriram
    CANCER RESEARCH, 2017, 77
  • [9] Comprehensive analyzing the expression of IDO1 and TDO2 in bladder cancer.
    Quoc Thang Pham
    Thanh Tu Nguyen
    Thao Quyen Nguyen
    Duc Tung Luu
    Thi Nhu Diem Pham
    Thi Thanh Tam Bui
    Thanh Tu Duong
    Dang Anh Thu Phan
    Quoc Dat Ngo
    CANCER RESEARCH, 2022, 82 (12)
  • [10] CHARACTERIZING IDO1 AND ITS THERAPEUTIC POTENTIAL IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
    Lauing, Kristen L.
    Lulla, Rishi R.
    Zhai, Lijie
    Hashizume, Rintaro
    Fangusaro, Jason
    Wainwright, Derek A.
    NEURO-ONCOLOGY, 2017, 19 : 32 - 32
12345